Publications by authors named "Holcombe E Grier"

62Publications

Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.

Pediatr Blood Cancer 2020 Nov 21:e28807. Epub 2020 Nov 21.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28807DOI Listing
November 2020

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

J Clin Oncol 2016 09 11;34(25):3031-8. Epub 2016 Jul 11.

Joanne P. Lagmay, Shands Hospital for Children, University of Florida, Gainesville, FL; Mark D. Krailo and Ha Dang, University of Southern California, Los Angeles; and Children's Oncology Group, Monrovia; Theodore Zwerdling, Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital, Long Beach, CA; AeRang Kim, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Orren Beaty III, Zeiss Children's Cancer Center, Mission Hospitals, Asheville, NC; Brigitte C. Widemann, National Institutes of Health Clinical Center, Bethesda, MD; Lisa Bomgaars and Susan M. Blaney, Baylor College of Medicine/Texas Children's Cancer Center, Houston; Anne-Marie Langevin, University of Texas Health Science Center at San Antonio, San Antonio, TX; Holcombe E. Grier and Katherine A. Janeway, Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, MA; Brenda Weigel, University of Minnesota, Minneapolis, MN; and Richard Gorlick, The Albert Einstein College of Medicine of Yeshiva University, The Children's Hospital at Montefiore, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.5381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012712PMC
September 2016

Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report.

Sarcoma 2015 5;2015:927123. Epub 2015 Oct 5.

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90027, USA ; Children's Oncology Group Statistics, Monrovia, CA 91016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/927123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609872PMC
October 2015

Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Pediatr Blood Cancer 2016 Jan 10;63(1):47-53. Epub 2015 Aug 10.

Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011751PMC
January 2016

Comparing oxazaphosphorines for treating Ewing sarcoma: is the answer important two decades later?

J Clin Oncol 2014 Aug 30;32(23):2401-2. Epub 2014 Jun 30.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.3379
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.3379DOI Listing
August 2014

Myogenic tumors in nevoid Basal cell carcinoma syndrome.

J Pediatr Hematol Oncol 2015 Mar;37(2):147-9

*Department of Pediatric Oncology, Dana-Farber Cancer Institute †Division of Pediatric Hematology/Oncology, Boston Children's Hospital ¶Department of Pathology, Boston Children's Hospital ‡Howard Hughes Medical Institute §Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University ∥Joslin Diabetes Center #Department of Pathology, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127382PMC
March 2015

Mutations in Hedgehog pathway genes in fetal rhabdomyomas.

J Pathol 2013 Sep;231(1):44-52

Howard Hughes Medical Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Harvard Stem Cell Institute, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875333PMC
September 2013

Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.

Pediatr Blood Cancer 2013 Jul 31;60(7):1108-12. Epub 2012 Dec 31.

Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646066PMC
July 2013

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

J Clin Oncol 2012 Nov 22;30(33):4148-54. Epub 2012 Oct 22.

Division of Oncology, CTRB 10, The Children's Hospital of Philadelphia, University of Pennsylvania, 3501 Civic Center Blvd, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.5703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494838PMC
November 2012

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Cancer 2012 Sep 17;118(18):4597-605. Epub 2012 Jan 17.

Department of Pediatric Hematology-Oncology, Dana-Farber/Children's Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008337PMC
September 2012

Parents' roles in decision making for children with cancer in the first year of cancer treatment.

J Clin Oncol 2011 May 4;29(15):2085-90. Epub 2011 Apr 4.

Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.0507DOI Listing
May 2011

Training program in cancer and blood diseases: Pediatric Hematology/Oncology Fellowship Program, Children's Hospital Boston/Dana-Farber Cancer Institute.

Am J Hematol 2010 Oct;85(10):793-4

Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21816DOI Listing
October 2010

Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.

Lancet Oncol 2010 Jul 27;11(7):670-8. Epub 2010 Mar 27.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital Boston, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147020451070062
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(10)70062-0DOI Listing
July 2010

Peace of mind and sense of purpose as core existential issues among parents of children with cancer.

Arch Pediatr Adolesc Med 2009 Jun;163(6):519-24

Department of Medicine, Children's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archpediatrics.2009.57DOI Listing
June 2009

Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.

Nat Rev Clin Oncol 2009 May;6(5):251-3

University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.25DOI Listing
May 2009

Ototoxicity in children treated for osteosarcoma.

Pediatr Blood Cancer 2009 Mar;52(3):387-91

Department of Pediatric Hematology/Oncology, Dana Farber-Cancer Institute/Children's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21875DOI Listing
March 2009

Late recurrence of ewing sarcoma during pregnancy: a report of 2 cases.

J Pediatr Hematol Oncol 2008 Sep;30(9):716-8

Department of Pediatrics, University of California, San Francisco, CA 94143-0106, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00043426-200809000-000
Publisher Site
http://dx.doi.org/10.1097/MPH.0b013e318175895fDOI Listing
September 2008

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.

Pediatr Blood Cancer 2008 Aug;51(2):163-70

Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21596DOI Listing
August 2008

Easing of suffering in children with cancer at the end of life: is care changing?

J Clin Oncol 2008 Apr;26(10):1717-23

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 44 Binney St, SM-205, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.0277DOI Listing
April 2008

Hope and prognostic disclosure.

J Clin Oncol 2007 Dec;25(35):5636-42

Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.12.6110
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.12.6110DOI Listing
December 2007

Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.

J Clin Oncol 2007 May;25(15):2057-62

Hasbro Children's Hospital/Brown Medical School, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.7776DOI Listing
May 2007

Early lymphocyte recovery in Ewing sarcoma.

J Pediatr Hematol Oncol 2007 May;29(5):351-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3180590627DOI Listing
May 2007

Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.

J Clin Oncol 2007 Apr;25(11):1357-62

Department of Pediatric Oncology, and the Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2006.08.3170
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.08.3170DOI Listing
April 2007

Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information.

J Clin Oncol 2006 Nov;24(33):5265-70

Departments of Pediatric Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2006.06.5326
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.06.5326DOI Listing
November 2006

Telling children and adolescents about their cancer diagnosis: Cross-cultural comparisons between pediatric oncologists in the US and Japan.

Psychooncology 2007 Jan;16(1):60-8

Center on Child and Family Outcomes, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1048DOI Listing
January 2007

Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience.

Arch Otolaryngol Head Neck Surg 2006 Apr;132(4):375-80

Department of Otolaryngology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://archotol.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archotol.132.4.375DOI Listing
April 2006

Parent and physician perspectives on quality of care at the end of life in children with cancer.

J Clin Oncol 2005 Dec 19;23(36):9155-61. Epub 2005 Sep 19.

Department of Pediatric Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.010DOI Listing
December 2005

Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.

Int J Radiat Oncol Biol Phys 2004 Mar;58(4):1208-14

Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2003.08.027DOI Listing
March 2004

The Day One Talk.

J Clin Oncol 2004 Feb;22(3):563-6

Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital, 44 Binney Street, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.04.078DOI Listing
February 2004

Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.

J Pediatr Hematol Oncol 2003 Dec;25(12):934-40

Division of Radiation Oncology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200312000-00005DOI Listing
December 2003

BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Cancer Res 2003 Jan;63(2):304-7

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
January 2003

Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston.

J Pediatr Hematol Oncol 2002 Dec;24(9):722-6

Department of Pediatric Hematology-Oncology, University of California-San Francisco, San Francisco, CA 94143-0519, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200212000-00008DOI Listing
December 2002

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

J Clin Oncol 2002 Jan;20(2):426-33

Dana-Farber Cancer Institute, The Children's Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.2.426DOI Listing
January 2002